inosine pranobex 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4576 36703-88-5

Description:

MoleculeDescription

Synonyms:

  • inosine pranobex
  • isoprinosin
An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly.
  • Molecular weight: 550.57
  • Formula: C24H34N6O9
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 129.20
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
3 g O

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Jan. 1, 1981 YEAR INTRODUCED

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC J05AX05 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIVIRALS FOR SYSTEMIC USE
DIRECT ACTING ANTIVIRALS
Other antivirals
MeSH PA D000276 Adjuvants, Immunologic
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000998 Antiviral Agents
MeSH PA D007155 Immunologic Factors

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01995 KEGG_DRUG
N0000170644 NUI
CHEMBL3833327 ChEMBL_ID
CHEMBL3833405 ChEMBL_ID
DB13156 DRUGBANK_ID
W1SO0V223F UNII
6048 RXNORM
003902 NDDF
324757004 SNOMEDCT_US
395749001 SNOMEDCT_US
C0022230 UMLSCUI
D007542 MESH_DESCRIPTOR_UI
135449284 PUBCHEM_CID

Pharmaceutical products:

None